234 related articles for article (PubMed ID: 9176171)
21. Sympathetic drive to liver and nonhepatic splanchnic tissue during prolonged exercise is increased in diabetes.
Coker RH; Krishna MG; Zinker BA; Allen EJ; Lacy DB; Wasserman DH
Metabolism; 1997 Nov; 46(11):1327-32. PubMed ID: 9361694
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
Sakurai H; Dobbs R; Unger RH
J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
[TBL] [Abstract][Full Text] [Related]
23. Role of carotid bodies in control of the neuroendocrine response to exercise.
Koyama Y; Coker RH; Denny JC; Lacy DB; Jabbour K; Williams PE; Wasserman DH
Am J Physiol Endocrinol Metab; 2001 Oct; 281(4):E742-8. PubMed ID: 11551850
[TBL] [Abstract][Full Text] [Related]
24. The effects of epinephrine on islet hormone secretion in the dog.
Ahrén B; Veith RC; Taborsky GJ
Int J Pancreatol; 1988 Jul; 3(5):375-88. PubMed ID: 2902147
[TBL] [Abstract][Full Text] [Related]
25. Biological actions of peptide YY: effects on endocrine pancreas, pituitary-adrenal axis, and plasma catecholamine concentrations in the dog.
Inui A; Inoue T; Sakatani N; Oya M; Morioka H; Mizuno N; Baba S
Horm Metab Res; 1987 Aug; 19(8):353-7. PubMed ID: 2822559
[TBL] [Abstract][Full Text] [Related]
26. The role of the autonomic nervous system in the control of glucagon, insulin and pancreatic polypeptide release from the pancreas.
Bloom SR; Edwards AV; Hardy RN
J Physiol; 1978 Jul; 280():9-23. PubMed ID: 690943
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic and extrapancreatic galanin release during sympathetic neural activation.
Dunning BE; Havel PJ; Veith RC; Taborsky GJ
Am J Physiol; 1990 Mar; 258(3 Pt 1):E436-44. PubMed ID: 1690516
[TBL] [Abstract][Full Text] [Related]
28. Effect of functional adrenalectomy on glucagon secretion and circulating catecholamines during insulin hypoglycemia in the dog.
Yamaguchi N; Briand R; Gaspo R
Can J Physiol Pharmacol; 1990 Sep; 68(9):1183-8. PubMed ID: 2276081
[TBL] [Abstract][Full Text] [Related]
29. Comparison of hepatic extraction of insulin and glucagon in conscious and anesthetized dogs.
Ishida T; Lewis RM; Hartley CJ; Entman ML; Field JB
Endocrinology; 1983 Mar; 112(3):1098-109. PubMed ID: 6337043
[TBL] [Abstract][Full Text] [Related]
30. In vivo stimulation of pancreatic hormone secretion by norepinephrine infusion in the dog.
Ribes G; Trimble ER; Blayac JP; Wollheim CB; Loubatières-Mariani MM
Am J Physiol; 1984 Apr; 246(4 Pt 1):E339-43. PubMed ID: 6144271
[TBL] [Abstract][Full Text] [Related]
31. Evidence that vasoactive intestinal polypeptide is a parasympathetic neurotransmitter in the endocrine pancreas in dogs.
Havel PJ; Dunning BE; Verchere CB; Baskin DG; O'Dorisio T; Taborsky GJ
Regul Pept; 1997 Aug; 71(3):163-70. PubMed ID: 9350974
[TBL] [Abstract][Full Text] [Related]
32. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
33. Autonomic mediation of glucagon secretion during insulin-induced hypoglycemia in rhesus monkeys.
Havel PJ; Valverde C
Diabetes; 1996 Jul; 45(7):960-6. PubMed ID: 8666149
[TBL] [Abstract][Full Text] [Related]
34. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
Liang Y; Cincotta AH
Int J Obes Relat Metab Disord; 2001 May; 25(5):698-704. PubMed ID: 11360153
[TBL] [Abstract][Full Text] [Related]
35. Effect of plasma amino acid replacement on glucagon and substrate responses to insulin-induced hypoglycemia in humans.
Nair KS; Welle SL; Tito J
Diabetes; 1990 Mar; 39(3):376-82. PubMed ID: 2407585
[TBL] [Abstract][Full Text] [Related]
36. Co-impairment of autonomic and glucagon responses to insulin-induced hypoglycemia in dogs with naturally occurring insulin-dependent diabetes mellitus.
Gilor C; Duesberg C; Elliott DA; Feldman EC; Mundinger TO; Taborsky GJ; Nelson RW; Havel PJ
Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1074-E1083. PubMed ID: 33044845
[TBL] [Abstract][Full Text] [Related]
37. Modulation of hormone secretion by functional electrical stimulation of the intact and incompletely dysfunctional dog pancreas.
Rozman J; Bunc M; Zorko B
Braz J Med Biol Res; 2004 Mar; 37(3):363-70. PubMed ID: 15060704
[TBL] [Abstract][Full Text] [Related]
38. Effect of splanchnic nerve stimulation on glucagon and insulin output in the dog.
Kaneto A; Kajinuma H; Kosaka K
Endocrinology; 1975 Jan; 96(1):143-50. PubMed ID: 1109899
[TBL] [Abstract][Full Text] [Related]
39. Effects of pancreastatin on pancreatic hormone secretion in the dog.
Ribes G; Vecina F; Hillaire-Buys D; Ahren B
Horm Res; 1990; 33(5):194-8. PubMed ID: 1980260
[TBL] [Abstract][Full Text] [Related]
40. Effect of opiate-receptor blockade on normoglycemic and hypoglycemic glucoregulation.
el-Tayeb KM; Brubaker PL; Lickley HL; Cook E; Vranic M
Am J Physiol; 1986 Mar; 250(3 Pt 1):E236-42. PubMed ID: 3006509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
